In relation to the news that a Philadelphia company that sells software used in hundreds of clinical trials, including the crash effort to develop tests, treatments and a vaccine for the coronavirus, was hit by a ransomware attack that has slowed some of those trials over the past two weeks, please find commentary on this below.
In relation to the news that a Philadelphia company that sells software used in hundreds of clinical trials, including the crash effort to develop tests, treatments and a vaccine for the coronavirus, was hit by a ransomware attack that has slowed some of those trials over the past two weeks, please find commentary on this below.